Lecanemab

Lecanemab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Lecanemab is an amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology. It is for use in people who have only one or no copy of ApoE4, a certain form of the gene for the protein apolipoprotein E, and who have amyloid beta plaques in the brain.

Lecanemab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Lecanemab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32435	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8615965530500	nickzhang@hangyubiotech.com	China	8510	58
Wuhan Jingkang en Biomedical Technology Co., Ltd	+8613720134139	orders@jknbiochem.com	China	5221	58
Wuhan Sunrise Technology Development Co., Ltd.	27-027-83314682 13554138826	whsrtech@vip.163.com	China	246	62
Nanjing Sunlida Biological Technology Co., Ltd.	025-57798810	sales@sunlidabio.com	China	3239	55
Shanghai URChem Limited	+86-021-50890968，021-50891159 +86-18601776121	danny@urchem.com	China	628	58
Shanghai Macklin Biochemical Co.,Ltd.	15221275939	shenlinxing@macklin.cn	China	15873	55
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9803	58
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62

---

• Lecanemab
• Research Grade Lecanemab (DHC12506)
• BAN-2401
• Lecanemab (anti-Amyloid Beta)
• 1260393-98-3